BIOX logo

Bioceres Crop Solutions Corp. (BIOX)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Bioceres Crop Solutions Corp. (BIOX) ist im Basic Materials-Sektor taetig, zuletzt notiert bei $0.40 mit einer Marktkapitalisierung von 26M. Bewertet mit 42/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 8. Feb. 2026
42/100 KI-Bewertung Ziel $2.00 (+401.4%) MCap 26M Vol 107K

Bioceres Crop Solutions Corp. (BIOX) Werkstoff- & Rohstoffexposure

CEOFederico Trucco
Mitarbeiter400
HauptsitzRosario, AR
IPO-Jahr2018

Bioceres Crop Solutions Corp. (BIOX) is revolutionizing agriculture with its innovative HB4 drought-tolerant technology and comprehensive suite of crop productivity solutions, positioning it as a key player in sustainable farming across Argentina, Uruguay, France, South Africa, and beyond.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 8. Feb. 2026

Investmentthese

Bioceres Crop Solutions Corp. presents a notable research candidate due to its focus on sustainable agriculture and innovative technologies like HB4 drought-tolerant seeds. With a market capitalization of $0.04 billion, BIOX is positioned for growth as climate change necessitates more resilient crop solutions. The company's diverse product portfolio across seed, crop protection, and nutrition segments provides multiple revenue streams. While the company currently has a negative P/E ratio of -0.68 and a negative profit margin of -16.6%, the gross margin of 39.1% indicates potential for improved profitability. Key catalysts include the expansion of HB4 technology adoption and strategic partnerships to penetrate new markets. Investors may want to evaluate BIOX for its long-term growth potential in the evolving agricultural landscape.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market Cap of $0.04B reflects the company's current valuation in the agricultural inputs market.
  • Gross Margin of 39.1% demonstrates the company's ability to generate revenue from its products and services.
  • Beta of 0.48 indicates lower volatility compared to the overall market, suggesting a relatively stable investment.
  • Operations in Argentina, Uruguay, France, and South Africa provide geographic diversification and access to different agricultural markets.
  • HB4 drought-tolerant seed technology offers a competitive advantage in regions facing water scarcity.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Innovative HB4 drought-tolerant technology.
  • Diversified product portfolio across seed, crop protection, and nutrition.
  • Established presence in key agricultural markets.
  • Strong focus on sustainable agriculture.

Schwaechen

  • Negative profit margin.
  • Relatively small market capitalization.
  • Dependence on regulatory approvals for HB4 technology.
  • Exposure to currency fluctuations in Argentina.

Katalysatoren

  • Upcoming: Regulatory approvals for HB4 technology in key markets.
  • Ongoing: Expansion of HB4 seed sales in existing markets.
  • Ongoing: Strategic partnerships to expand product portfolio and geographic reach.
  • Ongoing: Increased adoption of biological crop inputs.

Risiken

  • Potential: Delays in regulatory approvals for HB4 technology.
  • Potential: Competition from larger agricultural companies.
  • Ongoing: Fluctuations in commodity prices.
  • Ongoing: Adverse weather conditions impacting crop yields.
  • Potential: Currency fluctuations in Argentina affecting financial results.

Wachstumschancen

  • Expansion of HB4 Technology: Bioceres has a significant growth opportunity in expanding the adoption of its HB4 drought-tolerant technology. As climate change intensifies, the demand for drought-resistant crops will increase. The market for drought-tolerant seeds is projected to grow substantially, offering Bioceres a first-mover advantage in regions facing water scarcity. Successful trials and regulatory approvals in key markets will be crucial for realizing this growth potential. This expansion can occur over the next 3-5 years.
  • Strategic Partnerships and Acquisitions: Bioceres can pursue strategic partnerships and acquisitions to expand its product portfolio and geographic reach. Collaborating with other agricultural companies or acquiring complementary businesses can provide access to new technologies, markets, and distribution channels. This strategy can accelerate growth and enhance Bioceres' competitive position in the global agricultural inputs market. The timeline for such partnerships and acquisitions is ongoing.
  • Increased Adoption of Biologicals: The growing demand for sustainable agriculture is driving the adoption of biological crop inputs, such as inoculants and bio-inductors. Bioceres is well-positioned to capitalize on this trend through its Crop Nutrition segment. Expanding the production and marketing of biological fertilizers can drive revenue growth and enhance the company's reputation as a provider of environmentally friendly solutions. This is an ongoing trend with increasing market demand.
  • Penetration of New Geographic Markets: Bioceres currently operates in Argentina, Uruguay, France, and South Africa. Expanding into new geographic markets, particularly in regions with similar agricultural conditions, can drive significant growth. Identifying and targeting key markets with unmet needs for crop productivity solutions can provide new revenue streams and diversify the company's geographic footprint. This expansion can be phased over the next 5-7 years.
  • Development of Integrated Solutions: Bioceres can further integrate its seed, crop protection, and crop nutrition offerings to provide comprehensive solutions to farmers. By bundling products and services, the company can offer greater value to customers and increase customer loyalty. This integrated approach can differentiate Bioceres from its competitors and drive revenue growth through cross-selling and upselling opportunities. This is an ongoing strategy to enhance customer value.

Chancen

  • Expansion of HB4 technology adoption.
  • Strategic partnerships and acquisitions.
  • Increased adoption of biologicals.
  • Penetration of new geographic markets.

Risiken

  • Competition from larger agricultural companies.
  • Changes in government regulations.
  • Fluctuations in commodity prices.
  • Adverse weather conditions.

Wettbewerbsvorteile

  • Proprietary HB4 drought-tolerant technology.
  • Integrated solutions across seed, crop protection, and nutrition.
  • Established presence in key agricultural markets.
  • Strong relationships with farmers and distributors.

Ueber BIOX

Founded in 2001 and headquartered in Rosario, Argentina, Bioceres Crop Solutions Corp. has evolved into a prominent provider of crop productivity solutions. The company operates through three key segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment focuses on developing and commercializing cutting-edge seed technology, biotechnological events, superior germplasm, and advanced seed treatments designed to enhance crop yields and resilience. The Crop Protection segment is dedicated to producing and marketing a range of solutions, including Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits, providing farmers with the tools they need to protect their crops from pests and diseases. The Crop Nutrition segment develops, produces, and commercializes inoculants, bio-inductors, and biological and microgranulated fertilizers, promoting sustainable and efficient nutrient uptake by plants. A cornerstone of Bioceres' offerings is HB4, a proprietary drought-tolerant seed technology program that addresses the growing challenges posed by climate change. Operating in Argentina, Uruguay, France, South Africa, and other international markets, Bioceres is committed to driving agricultural innovation and sustainability on a global scale. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.

Was das Unternehmen tut

  • Develop and commercialize seed technology and biotechnological events.
  • Produce and market crop protection products, including herbicides, insecticides, and fungicides.
  • Develop and sell crop nutrition products, such as inoculants and bio-inductors.
  • Offer HB4 drought-tolerant seed technology.
  • Provide solutions for sustainable agriculture.
  • Operate in Argentina, Uruguay, France, and South Africa.

Geschaeftsmodell

  • Sales of seed and integrated products.
  • Sales of crop protection products.
  • Sales of crop nutrition products.
  • Licensing of HB4 technology.
  • Distribution through a network of retailers and distributors.

Branchenkontext

Bioceres Crop Solutions operates within the agricultural inputs industry, a sector experiencing increased demand for sustainable and efficient farming solutions. The global agricultural inputs market is projected to reach billions of dollars, driven by the need to feed a growing population while minimizing environmental impact. Key trends include the adoption of precision agriculture, the use of biologicals, and the development of climate-resilient crops. Bioceres competes with companies like ACNT, AEC, ATLX, AVD, and FSI, all vying for market share by offering innovative products and services to farmers. Bioceres' focus on HB4 technology and integrated solutions positions it as a key player in this evolving landscape.

Wichtige Kunden

  • Farmers in Argentina, Uruguay, France, and South Africa.
  • Agricultural retailers and distributors.
  • Seed companies.
  • Food producers.
KI-Zuversicht: 72% Aktualisiert: 8. Feb. 2026

Finanzdaten

Chart & Info

Bioceres Crop Solutions Corp. (BIOX) Aktienkurs: $0.40 (-0.02, -5.43%)

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer BIOX.

Kursziele

Konsens-Kursziel: $2.00

MoonshotScore

42/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von BIOX auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

BIOX Basic Materials Aktien-FAQ

What are the key factors to evaluate for BIOX?

Bioceres Crop Solutions Corp. (BIOX) currently holds an AI score of 42/100, indicating low score. Analysts target $2.00 (+401% from $0.40). Key strength: Innovative HB4 drought-tolerant technology.. Primary risk to monitor: Potential: Delays in regulatory approvals for HB4 technology.. This is not financial advice.

How frequently does BIOX data refresh on this page?

BIOX prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven BIOX's recent stock price performance?

Recent price movement in Bioceres Crop Solutions Corp. (BIOX) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $2.00 implies 401% upside from here. Notable catalyst: Innovative HB4 drought-tolerant technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider BIOX overvalued or undervalued right now?

Determining whether Bioceres Crop Solutions Corp. (BIOX) is overvalued or undervalued requires examining multiple metrics. Analysts target $2.00 (+401% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying BIOX?

Before investing in Bioceres Crop Solutions Corp. (BIOX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding BIOX to a portfolio?

Potential reasons to consider Bioceres Crop Solutions Corp. (BIOX) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Innovative HB4 drought-tolerant technology.. Additionally: Diversified product portfolio across seed, crop protection, and nutrition.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of BIOX?

Yes, most major brokerages offer fractional shares of Bioceres Crop Solutions Corp. (BIOX) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track BIOX's earnings and financial reports?

Bioceres Crop Solutions Corp. (BIOX) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for BIOX earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Financial data may be subject to restatement.
  • Future performance is not guaranteed.
  • Investment decisions should be based on thorough research and consultation with a financial advisor.
Datenquellen

Popular Stocks